NLRP3 and colitis: NLRP3(−/−) mice exhibited resistance to colon mucosal damage and relieved colitis in the DSS or TNBS (2,4,6-trinitrobenzene sulfonic acid) model [40–42], and IL-10(−/−) model [43, 44], with reduced mortality.